- What ICH E6(R3) Actually Changes
- The July 15, 2026 Transition: What It Means for Your Exam
- Domain-by-Domain Impact of E6(R3)
- Risk-Based and Proportionate Oversight: The Central Shift
- Ethical and Safety Considerations Under E6(R3)
- Sequencing Your E6(R3) Preparation Across Domains
- How E6(R3) Concepts Appear in ACRP-PI Exam Questions
- Registration, Fees, and Scheduling Context
- Frequently Asked Questions
- ICH E6(R3) officially replaces E6(R2) on the ACRP-PI exam beginning July 15, 2026-candidates must confirm which version applies to their test date.
- Ethical and Safety Considerations is the highest-weighted domain at 22%, and E6(R3) directly reshapes sponsor and PI accountability expectations tested there.
- The 2024 CPI exam content outline governs all six domains; aligning E6(R3) principles to each domain percentage is the most efficient preparation strategy.
- Risk-based quality management (RBQM) and proportionate oversight are new structural pillars of E6(R3) that appear across Clinical Trial Operations and Data...
What ICH E6(R3) Actually Changes
The International Council for Harmonisation's E6(R3) guideline is not a minor revision. It represents the first comprehensive restructuring of Good Clinical Practice (GCP) since E6(R1) was issued in 1996, and it goes well beyond the targeted risk-based monitoring additions introduced in E6(R2). For candidates pursuing the Certified Principal Investigator credential, understanding precisely what changed-and why it matters at the site level-is non-negotiable preparation.
At its core, E6(R3) is organized into two main parts. Part I covers general GCP principles applicable across all clinical investigations. Part II addresses specific considerations for interventional clinical trials. This architectural change matters because the exam tests your ability to apply principles contextually, not just recall definitions. A question may present a protocol scenario and ask which E6(R3) obligation governs the PI's decision-and knowing that Part I covers general responsibilities while Part II handles trial-specific procedures helps you reason through the answer.
Key substantive changes in E6(R3) include: expanded definitions of roles and responsibilities (particularly for sponsors and investigators in decentralized contexts), a formal framework for risk-based quality management (RBQM) at the trial design stage, updated informed consent requirements addressing remote and electronic consent, revised documentation standards that accommodate modern electronic systems, and clarified expectations around trial master file (TMF) structure and real-time access.
The July 15, 2026 Transition: What It Means for Your Exam
The ACRP-PI exam will test ICH E6(R3) beginning July 15, 2026. Before that date, E6(R2) remains the operative guideline on the exam. This is not an ambiguous cutover-it is a hard date that should anchor your study planning.
If you are scheduled to test before July 15, 2026, your primary GCP reference remains E6(R2). However, studying E6(R3) in parallel is still worthwhile because the underlying principles of PI accountability, subject protection, and data integrity are consistent across versions. The substantive differences-RBQM formalization, proportionate oversight language, decentralized trial provisions-are what change.
If you are testing on or after July 15, 2026, E6(R3) is your governing guideline. Given that exam registration opens and candidates often schedule months in advance, this means anyone registering now for a fall 2026 exam date should orient their preparation entirely around E6(R3) content.
For a full walkthrough of confirming your eligibility and scheduling through PSI (either at an in-person test center or via live remote proctoring), the ACRP-PI Application Process: Step-by-Step 2026 Guide covers each stage in detail, including how to select your testing modality and what documentation ACRP requires before your application is approved.
Domain-by-Domain Impact of E6(R3)
The ACRP-PI exam is organized around six domains drawn from the 2024 CPI content outline. E6(R3) does not affect each domain equally-some domains are structurally transformed while others see more targeted updates. Here is how to think about each.
Domain 1: Scientific Rationale and Principles of Research Design (15%)
E6(R3) reinforces the expectation that PIs understand the scientific basis of a trial before agreeing to conduct it. The guideline's emphasis on fit-for-purpose design means exam questions may ask how a PI evaluates whether a protocol's design is appropriate for its stated objectives.
- Protocol feasibility assessment through an E6(R3) lens
- PI responsibilities in reviewing scientific rationale documentation
- Risk identification at the design stage (new RBQM framing)
Domain 2: Ethical and Safety Considerations (22%)
The highest-weighted domain. E6(R3) expands and clarifies informed consent requirements, including provisions for electronic and remote consent processes. IRB/IEC submission and ongoing oversight expectations are also updated.
- Remote and eConsent procedures under E6(R3)
- Ongoing informed consent during long-duration or adaptive trials
- Adverse event reporting obligations specific to PI role
- Vulnerable population protections and proportionality
Domain 3: Product Development and Regulation (12%)
E6(R3) is an ICH-only guideline-it is not country-specific-which directly aligns with this domain's regulatory framework content. Candidates must understand how GCP principles interact with investigational product accountability without anchoring to a single national regulator.
- Investigational product handling under updated GCP documentation standards
- Sponsor-investigator accountability in multinational contexts
Domain 4: Clinical Trial Operations (21%)
The second-highest weighted domain sees significant E6(R3) impact. Risk-based monitoring, centralized monitoring, and decentralized trial operations (DCTs) are all addressed in the updated guideline. PIs must understand their oversight obligations when monitoring is conducted remotely or through centralized data review.
- PI obligations during risk-based monitoring visits
- Decentralized trial operations: PI accountability for remote visits
- Delegation and oversight of sub-investigators under updated role definitions
- Site initiation, conduct, and closeout under revised TMF expectations
Domain 5: Study and Site Management (17%)
E6(R3) strengthens expectations around site-level quality systems and real-time documentation access. Study coordinators and site staff management questions in this domain increasingly reference proportionate oversight and quality tolerance limits (QTLs).
- Staff delegation logs and training documentation under E6(R3)
- Site quality systems and process improvement expectations
- TMF completeness and PI oversight responsibility
Domain 6: Data Management (13%)
E6(R3) modernizes expectations for electronic systems, audit trails, and data integrity. The updated guideline addresses computerized system validation in a way that reflects current technology, including cloud-based and hybrid eClinical platforms.
- Electronic data capture (EDC) audit trail requirements
- Source document definitions in decentralized and wearable data contexts
- Query management and PI accountability for data accuracy
Risk-Based and Proportionate Oversight: The Central Shift
If you could identify one conceptual thread that runs through every domain touched by E6(R3), it is the principle of proportionality. Under E6(R3), GCP compliance is not a uniform checklist-it is a risk-calibrated framework where the intensity of oversight should match the nature and complexity of the trial and the risks to participants.
For exam purposes, this means candidates must be able to distinguish between what a high-risk, complex interventional trial demands of a PI versus what a lower-risk observational or minimal-risk interventional study requires. E6(R3) explicitly supports this differentiation, and the ACRP-PI exam tests whether PIs understand their adaptive obligations-not just the maximum-standard baseline.
Risk-based quality management (RBQM) is the operational framework through which proportionality is implemented. RBQM involves identifying critical data and processes, defining quality tolerance limits, implementing centralized and/or remote monitoring, and triggering site-level actions when those limits are approached or breached. As PI, your role in RBQM is both to implement the sponsor's quality plan at your site and to escalate concerns when the plan proves inadequate.
Key Takeaway
Questions in Clinical Trial Operations (Domain 4) and Study and Site Management (Domain 5) will increasingly present RBQM scenarios under E6(R3). Practice identifying which RBQM element a scenario is testing-risk identification, QTL definition, monitoring response, or escalation-before selecting your answer. The ACRP-PI practice test platform includes scenario-based questions designed around these multi-step reasoning tasks.
Ethical and Safety Considerations Under E6(R3)
Domain 2 carries the highest exam weight at 22%, and E6(R3) makes several changes that directly affect what a PI is expected to know and do in this space. Candidates who treat informed consent as a static, checklist-based activity will struggle with the nuanced questions this domain generates.
Updated Informed Consent Requirements
E6(R3) formally addresses electronic informed consent (eConsent) and remote consent processes, reflecting the reality of decentralized and hybrid trials. For PIs, this means understanding not only when electronic consent is appropriate, but also how to ensure the process meets the ethical standards of voluntariness, comprehension, and documentation regardless of the medium used. The guideline also emphasizes ongoing consent-the PI's obligation to re-consent participants when new information emerges that may affect their willingness to continue.
Adverse Event Reporting and the PI's Accountability Chain
E6(R3) clarifies the investigator's responsibility in the adverse event reporting chain, particularly in distinguishing between reportable events to the sponsor, IRB/IEC obligations, and what constitutes an unanticipated problem involving risks to participants. Exam questions in Domain 2 frequently test this three-way reporting logic, and candidates must be able to apply E6(R3)'s updated language-not E6(R2)'s older framing-to novel scenarios.
Sequencing Your E6(R3) Preparation Across Domains
Given the domain weights and the specific E6(R3) changes outlined above, here is a practical preparation sequence that prioritizes exam impact:
E6(R3) Foundation + Domain 2 (Ethical and Safety, 22%)
- Read ICH E6(R3) Part I in full; annotate PI-specific obligations
- Map consent, AE reporting, and vulnerability safeguards to Domain 2 tasks
- Complete practice questions focused on eConsent and ongoing consent scenarios
Domain 4 (Clinical Trial Operations, 21%) + RBQM Deep Dive
- Read ICH E6(R3) Part II sections on monitoring and site responsibilities
- Study RBQM framework: risk identification, QTLs, monitoring response
- Practice decentralized trial and centralized monitoring scenario questions
Domains 5 and 1 (Study/Site Management 17% + Scientific Rationale 15%)
- Focus on delegation, TMF obligations, and site quality systems
- Review protocol feasibility and PI sign-off responsibilities
- Use spaced repetition for E6(R3) definitions and role distinctions
Domains 6 and 3 (Data Management 13% + Product/Regulation 12%) + Full Practice Exam
- Cover EDC audit trails, source document definitions, and computerized system expectations
- Review investigational product accountability under updated GCP
- Take a timed, full-length practice exam at the ACRP-PI practice test platform
How E6(R3) Concepts Appear in ACRP-PI Exam Questions
The ACRP-PI exam delivers 125 multiple-choice questions in 180 minutes-a pace of roughly 86 seconds per question. The exam includes both scored and unscored pretest items, which are indistinguishable during testing, so every question must be treated as scored. The scaled passing score is 600.
E6(R3) questions are not definitional lookups. The exam format tests application: you are given a scenario, and you must identify the PI's correct action, obligation, or priority. This requires you to internalize E6(R3) principles well enough to reason through an unfamiliar situation, not just recall which section covers which topic.
| Question Type | E6(R3) Concept Tested | Relevant Domain |
|---|---|---|
| Scenario: remote consent process question | eConsent validity requirements, PI oversight obligation | Domain 2 (22%) |
| Scenario: sponsor reduces on-site monitoring frequency | RBQM, PI's obligation to flag data quality concerns | Domain 4 (21%) |
| Scenario: sub-investigator documents an unexpected AE | Delegation responsibilities, AE reporting chain | Domains 2 and 5 |
| Scenario: EDC audit trail discrepancy discovered | Data integrity, PI accountability for source data | Domain 6 (13%) |
| Scenario: protocol amendment mid-trial for vulnerable population | Re-consent obligations, IRB submission requirements | Domain 2 (22%) |
Practicing with this question style-where E6(R3) is applied to a situation rather than recalled from memory-is the most direct path to exam readiness. This is also why the ACRP-PI ICH E6(R3) Updates: What Candidates Must Know resource should be used alongside active question practice, not as a standalone read.
Registration, Fees, and Scheduling Context
Understanding the registration logistics matters because your testing window determines which guideline version you must master. The ACRP-PI exam is administered by PSI at in-person test centers or through live remote proctoring. ACRP members who register during the early-bird window pay $435; non-members pay $485 during early-bird. Regular registration fees are $460 for members and $600 for non-members. The cost differential makes confirming your member status before registering a worthwhile step.
Eligibility requires 3,000 hours performing essential PI activities, with documentation as PI or Sub-I on qualifying studies. Candidates following the doctoral/licensed provider route or Sub-I pathway must meet the specific proof requirements outlined by ACRP; qualifying waivers can reduce the hours requirement to 1,500. After earning the credential, maintenance requires 24 points every two years.
The exam is explicitly ICH-only and not country-specific, which is why E6(R3)'s international harmonization framework-rather than any single national regulation-is the governing standard. Candidates who prepare using country-specific regulatory frameworks as their primary GCP reference will find exam questions poorly calibrated to that approach. E6(R3) is the correct lens.
Frequently Asked Questions
No. If your exam date is before July 15, 2026, E6(R2) remains the operative GCP guideline on the exam. The transition to E6(R3) takes effect for all exams administered on or after that date. Confirm your test date before finalizing which version to prioritize in your preparation.
Domain 2 (Ethical and Safety Considerations) carries the highest exam weight at 22% and is directly affected by E6(R3)'s updated informed consent provisions, eConsent processes, and adverse event reporting language. Domain 4 (Clinical Trial Operations, 21%) is equally impacted by the RBQM and decentralized trial changes. Together, these two domains represent 43% of the exam.
The exam is explicitly ICH-only and not country-specific. This means E6(R3) GCP principles-rather than FDA CFR regulations or any single national regulatory framework-govern the content. Candidates should study E6(R3) as their primary GCP reference, not FDA guidance documents.
The exam uses a scaled scoring system with a passing score of 600. Because the exam includes both scored and unscored pretest items among its 125 questions, there is no fixed raw number of correct answers that maps directly to 600. Focus on consistent performance across all domains rather than targeting a specific raw count.
The ACRP-PI practice test platform at this site provides scenario-based questions mapped to all six exam domains and aligned to the 2024 CPI content outline, including E6(R3) application scenarios. Using timed, full-length practice exams is the most effective way to calibrate your readiness before the 180-minute, 125-question exam.